Marisa Wexler, MS

Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Marisa Wexler, MS

May 17, 2021 News by Marisa Wexler, MS

Marisa Wexler, MS

Articles by Marisa Wexler, MS

Mavenclad’s Ability to Lower RRMS Relapse Rates May Last Years, Study Says

New 3D Model May Help in Promoting Myelin, Preventing Its Loss

Safety of Oral DMTs for RRMS in Real-world Use Seen to Match Trial Findings

#AANAM – Exploring Mavenclad’s Effects on Immune Cells

#AANAM – Research Focuses on Measuring Therapeutic Lag

#AANAM – Early Ocrevus Treatment Helps to Protect Nervous System

#AANAM – Ocrevus, Rituximab Linked to More Severe COVID-19 Cases in Italy

#AANAM – Tysabri Improves Quality of Life, Can Reduce Infection Risk

#AANAM – COVID-19 Often Leads to Flares in MS Patients, Survey Finds

#AANAM – Abnormally Warm Weather Tied to More ER Visits

#AANAM – More Diversity Needed Among Neurologists, Presenters Agree

#AANAM – Disease Severity, Job Loss Higher in Black Than White Patients in US

#AANAM – Measuring Blood Proteins Could Predict Disability in SPMS

MS Has 3 Distinct Subtypes, Study of MRI Brain Patterns Using AI Reports

Mertk Gene Plays Key Role in Myelin Repair, Mouse Study Finds

Under-the-skin Injection of Tysabri Approved in Europe

Pediatric-onset MS Tied to Fewer School Years, Lower Income in Adulthood

N-acetyl Cysteine Safe, But Failed to Lessen MS Fatigue

Machine Learning of Walking Patterns Could Help Predict MS Progression

PoNS Device to Help Adults in Rehab for Walking Problems Gets FDA Approval

Rituximab Fails to Lessen Brain Inflammation in Progressive MS Trial

Certain Factors Worsen Outcomes in MS Patients With COVID-19

Ponvory (ponesimod) Approved for Adults With Relapsing Forms of MS

Novartis, iHeartRadio Team Up for ‘A Night for MS Awareness’ on March 11

#ACTRIMS2021 – Taking Medication During Pregnancy Reduces Healthcare Costs

#ACTRIMS2021 – Reduced Methionine in Diet Eased Symptoms in MS Mice

#ACTRIMS2021 – Dietary Restriction May Limit Severity of MS

#ACTRIMS2021 – Research Finds Race- and Ethnicity-based Differences in MS Therapies

#ACTRIMS2021 – Leptin’s Pro-inflammatory Effects May Link Obesity to MS

#ACTRIMS2021 – Neurologist Calls for Trial Testing Estrogen Therapy at Menopause

Subscribe to our newsletter